The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
Jornada de Demostración Tecnológica BACSI 2026.
La UCLM estará presente en las Jornadas de Demostración Tecnológica BACSI 2026 los días 18 y 19 de marzo, mostrando su capacidad investigadora y su papel como agente clave de innovación en Castilla‑La Mancha. La universidad participará conectando a sus grupos de...
Mar 3, 2026
















